Maxispas DS Syrup
By Maxispas
Rx
60ml Syrup in a Bottle

Composition
Mefenamic Acid(100mg/5ml) + Paracetamol(250mg/5ml)

Manufacturer - MaxQure Labs
No 129,Ground Floor, 2nd Main Road, Chamraj Pet Bangalore-560018

Expires on or after
September, 2025

liver
It is important to be cautious when using Maxispas DS Syrup in patients with liver disease, as dose adjustment may be necessary. It is advised to consult a doctor before using this syrup. However, Maxispas DS Syrup is not recommended for patients with severe liver disease or active liver disease.

kidney
Maxispas DS Syrup should be used with caution in patients with kidney disease. Dose adjustment may be necessary. Avoid using Maxispas DS Syrup in cases of severe kidney disease. Consult your doctor for guidance.

alcohol
It is unsafe to drink alcohol while taking Maxispas DS Syrup.

driving
Maxispas DS Syrup may reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Maxispas DS Syrup may be risky during pregnancy. Animal studies suggest potential harm to the baby. Consult your doctor for a careful evaluation of benefits and risks before using this medication.

breastfeeding
Maxispas DS Syrup is considered safe to use while breastfeeding. Research indicates that the medication does not transfer in significant quantities to breastmilk and poses no harm to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹55
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024